This study is looking at why people with peripheral neuropathy (nerve damage that can cause weakness, numbness, and pain) decide to join, leave, or rejoin clinical trials. There are no specific treatments being tested in this study. Instead, researchers want to understand what encourages or discourages participation. The goal is to improve future research so that new treatments for peripheral neuropathy can be developed faster. To be eligible, you must be at least 18 years old, have a diagnosis of peripheral neuropathy, and be able to understand and agree to the study. Pregnant or nursing women, or those unable to do electronic reporting, cannot join. The study will measure how many people enroll and how many stay in a trial for up to 12 months.

Study design

This is an observational study aiming to enroll 500 participants. It is not testing a specific treatment but rather observing trends in participation.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be observed for up to 12 months to see if they remain in a clinical trial.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.